Glycemic variability in patients with Wolfram syndrome is lower than in type 1 diabetes

AIMS: Wolfram syndrome (WFS) is diagnosed as coexistence of diabetes mellitus and optic atrophy, where pancreatic beta cell destruction is associated with neurodegeneration. Typically, WFS necessitates insulin treatment similar to type 1 diabetes (T1D), but the mechanism of beta cell mass reduction...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Acta Diabetol
Glavni autori: Zmyslowska, A., Fendler, W., Szadkowska, A., Borowiec, M., Mysliwiec, M., Baranowska-Jazwiecka, A., Buraczewska, M., Fulmanska-Anders, M., Mianowska, B., Pietrzak, I., Rzeznik, D., Mlynarski, W.
Format: Artigo
Jezik:Inglês
Izdano: Springer Milan 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4628085/
https://ncbi.nlm.nih.gov/pubmed/25916214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-015-0757-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items